the patient investor's blog

"you do you!" musings and observations about investing and sports and other editorial cuts

Friday, September 15, 2023

Letter to the RSSS Board

›
I've originally wrote about RSSS in the Long Cast 4Q22 letter, which can be found here . I think the new CEO, Roy Olivier, is operating ...
1 comment:
Tuesday, March 28, 2023

On Performance, Returns and Finding Ideas

›
A flooded basement isn't just a confrontation with nature but a reckoning with all the shit stored down there. Here's a long kept ad...
4 comments:
Wednesday, November 2, 2022

On Tracking Tigers + LCA 3Q22 Letter

›
I recently attended a small retreat for fund managers where one of the guest speakers, via video presentation from a game reserve in S. Afri...
Wednesday, July 13, 2022

Richardson is Having an Interesting Product Cycle

›
This is a product-based thesis. The company, Richardson Electronics (RELL), long a “dog” stock with a lousy corporate governance structure, ...
1 comment:
Wednesday, June 8, 2022

capital losses is tuition in the school of portfolio management

›
So CTEK is selling itself for $1.25 / share. The company is in a “go shop” period until the end of June and still publishing contract announ...
Tuesday, March 22, 2022

An Observation on High ROE Companies and their Market Caps

›
Been awhile since I've written here. I've cooled on the blog to focus on my investment business, Long Cast Advisers , which continue...
1 comment:
Thursday, May 20, 2021

on bugs and seeds (SANW)

›
We inhabit a world of bugs that has existed / will exist far longer than us and will feast on us when we are long gone. As a homeowner, I ha...
›
Home
View web version
Powered by Blogger.